Skip to main content
PharmaBlock Sciences (Nanjing), Inc. logo

PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings

Ticker · 300725 ISIN · CNE1000035K5 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,618 across all filing types
Latest filing 2023-12-13 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300725

About PharmaBlock Sciences (Nanjing), Inc.

https://www.pharmablock.com

PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.

Recent filings

Filing Released Lang Actions
战略委员会工作制度（2023年12月）
Governance Information Classification · 95% confidence The document is titled '战略委员会工作制度' (Strategic Committee Work System) and details the structure, responsibilities, and procedures of the company's strategic committee. It focuses on governance, committee composition, meeting rules, and oversight functions related to strategy and ESG matters. There is no financial data, earnings information, or regulatory filing content. The document is a governance-related internal policy or charter rather than a report or announcement. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-12-13 Chinese
关于2022年向不特定对象发行可转换公司债券募集资金使用完毕并注销募集资金专项账户的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the completion of the use of funds raised through a convertible bond issuance and the closure of the special account for those funds. It includes details about the bond issuance, fund management, and the account closure. The document is relatively short (1465 characters) and serves as a formal notification rather than a detailed financial report or audit. It does not contain financial statements or detailed analysis but rather informs stakeholders about the status of fundraising and fund usage. This fits the description of a Capital/Financing Update (CAP) as it relates to fundraising activities and capital management.
2023-12-12 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from a company regarding the progress of its share repurchase program. It details the number of shares repurchased, prices, compliance with regulatory guidelines, and future plans for the buyback. It does not contain financial statements or detailed financial analysis but is a regulatory disclosure about the company's transaction in its own shares. Therefore, it fits the category of 'Transaction in Own Shares' (POS). The document length is short and focused solely on the buyback progress, not a full financial report or earnings release.
2023-12-04 Chinese
关于首次回购公司股份的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the company's first repurchase of its own shares, detailing the number of shares repurchased, prices, compliance with regulatory guidelines, and future plans for share repurchase. It does not contain financial statements or detailed financial analysis but is a regulatory disclosure about a share buyback transaction. This fits the definition of a Transaction in Own Shares (POS) filing, which reports the company's buyback of its own shares.
2023-11-21 Chinese
关于控股股东、实际控制人部分股份质押及解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the pledge and release of shares by a controlling shareholder and actual controller of the company. It details the number of shares pledged, released, and cumulative pledges, along with dates and pledgees. There is no financial statement, earnings data, or management discussion. The document is a regulatory disclosure about share pledging activities by a major shareholder, which fits the category of Major Shareholding Notification (MRQ). The document length is short and focused solely on share pledge information, not a full report or announcement of a report publication. Therefore, the correct classification is MRQ.
2023-11-10 Chinese
关于变更投资者联系邮箱的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about changing its investor contact email address. It contains no financial data, no report content, no voting results, no management changes, no legal proceedings, or other substantive report information. It is a regulatory announcement related to investor relations contact information. The document length is only 449 characters, indicating it is a brief notice rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-11-03 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.